Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
Identifieur interne : 000051 ( PubMed/Curation ); précédent : 000050; suivant : 000052Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
Auteurs : Ambra Di Altobrando [Italie] ; Annalisa Patrizi [Italie] ; Federico Bardazzi [Italie]Source :
- Journal of the European Academy of Dermatology and Venereology : JEADV [ 1468-3083 ] ; 2020.
Abstract
In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID-19), scientific data relating to the causative virus SARS-CoV-2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner.
DOI: 10.1111/jdv.16491
PubMed: 32302437
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000051
Links to Exploration step
pubmed:32302437Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?</title>
<author><name sortKey="Di Altobrando, Ambra" sort="Di Altobrando, Ambra" uniqKey="Di Altobrando A" first="Ambra" last="Di Altobrando">Ambra Di Altobrando</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Patrizi, Annalisa" sort="Patrizi, Annalisa" uniqKey="Patrizi A" first="Annalisa" last="Patrizi">Annalisa Patrizi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bardazzi, Federico" sort="Bardazzi, Federico" uniqKey="Bardazzi F" first="Federico" last="Bardazzi">Federico Bardazzi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32302437</idno>
<idno type="pmid">32302437</idno>
<idno type="doi">10.1111/jdv.16491</idno>
<idno type="wicri:Area/PubMed/Corpus">000051</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000051</idno>
<idno type="wicri:Area/PubMed/Curation">000051</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000051</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?</title>
<author><name sortKey="Di Altobrando, Ambra" sort="Di Altobrando, Ambra" uniqKey="Di Altobrando A" first="Ambra" last="Di Altobrando">Ambra Di Altobrando</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Patrizi, Annalisa" sort="Patrizi, Annalisa" uniqKey="Patrizi A" first="Annalisa" last="Patrizi">Annalisa Patrizi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bardazzi, Federico" sort="Bardazzi, Federico" uniqKey="Bardazzi F" first="Federico" last="Bardazzi">Federico Bardazzi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the European Academy of Dermatology and Venereology : JEADV</title>
<idno type="eISSN">1468-3083</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID-19), scientific data relating to the causative virus SARS-CoV-2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32302437</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3083</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Apr</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title>
<ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation>
</Journal>
<ArticleTitle>Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.16491</ELocationID>
<Abstract><AbstractText>In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID-19), scientific data relating to the causative virus SARS-CoV-2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner.</AbstractText>
<CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Altobrando</LastName>
<ForeName>Ambra</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0003-3236-8822</Identifier>
<AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Patrizi</LastName>
<ForeName>Annalisa</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-8398-0483</Identifier>
<AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bardazzi</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA>
<NlmUniqueID>9216037</NlmUniqueID>
<ISSNLinking>0926-9959</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">blistering disorders</Keyword>
<Keyword MajorTopicYN="N">bullous disorders</Keyword>
<Keyword MajorTopicYN="N">immunosuppressive therapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32302437</ArticleId>
<ArticleId IdType="doi">10.1111/jdv.16491</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000051 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000051 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32302437 |texte= Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32302437" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |